119 related articles for article (PubMed ID: 4038468)
1. High-dose cisplatin in patients with advanced malignancies.
Blumenreich MS; Woodcock TM; Jones M; Richman SP; Gentile PS; Kubota TT; Allegra JC
Cancer; 1985 Mar; 55(5):1118-22. PubMed ID: 4038468
[TBL] [Abstract][Full Text] [Related]
2. Activity of JM9 in advanced ovarian cancer: a phase I-II trial.
Bramwell VH; Crowther D; O'Malley S; Swindell R; Johnson R; Cooper EH; Thatcher N; Howell A
Cancer Treat Rep; 1985 Apr; 69(4):409-16. PubMed ID: 3995511
[TBL] [Abstract][Full Text] [Related]
3. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
[TBL] [Abstract][Full Text] [Related]
4. Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms.
Trump DL; Hortvet L
Cancer Treat Rep; 1985 Mar; 69(3):259-61. PubMed ID: 2983893
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: a phase I-II study.
Wheeler R; Salter M; Stephens S; Hardy I; Peters G; Urist M; Maddox W
NCI Monogr; 1988; (6):339-41. PubMed ID: 3352778
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of continuous infusion cisplatin.
Posner MR; Ferrari L; Belliveau JF; Cummings FJ; Wiemann MC; O'Rourke A; Weitberg AB; Calabresi P
Cancer; 1987 Jan; 59(1):15-8. PubMed ID: 3791142
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian Carcinoma.
Piccart MJ; Nogaret JM; Marcelis L; Longrée H; Ries F; Kains JP; Gobert P; Domange AM; Sculier JP; Gompel C
J Natl Cancer Inst; 1990 Apr; 82(8):703-7. PubMed ID: 2181152
[TBL] [Abstract][Full Text] [Related]
8. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.
Herman TS; Jochelson MS; Teicher BA; Scott PJ; Hansen J; Clark JR; Pfeffer MR; Gelwan LE; Molnar-Griffin BJ; Fraser SM
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1273-9. PubMed ID: 2689396
[TBL] [Abstract][Full Text] [Related]
9. [Cisplatin administration for outpatients with short hydration of less than four hours].
Hata A; Katakami N; Masuda Y; Kaji R; Fujita S; Iwamori S; Horai A; Takatori K; Ose T; Kitajima N; Mifune Y; Fukae M
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1385-8. PubMed ID: 22996774
[TBL] [Abstract][Full Text] [Related]
10. [The effect of bismuth subnitrate on cisplatin toxicity].
Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
Tohnai I; Kawabe Y; Nakashima T; Yamagiwa M; Suzuki T; Mizuno A; Mineda H
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2567-78. PubMed ID: 1702133
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies.
Blumenreich MS; Woodcock TM; Richman SP; Jones MK; Gentile PS; Kubota TT; Allegra JC
Cancer; 1985 Jul; 56(2):256-8. PubMed ID: 4005796
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of ICRF-187 by 48-hour continuous infusion.
Koeller JM; Earhart RH; Davis HL
Cancer Treat Rep; 1981; 65(5-6):459-63. PubMed ID: 6786740
[TBL] [Abstract][Full Text] [Related]
14. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of cisplatin in advanced gastric cancer.
Beer M; Cocconi G; Ceci G; Varini M; Cavalli F
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):717-20. PubMed ID: 6683644
[TBL] [Abstract][Full Text] [Related]
16. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
[TBL] [Abstract][Full Text] [Related]
17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
18. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.
Markman M; D'Acquisto R; Iannotti N; Kris M; Hakes T; Bajorin D; Bosl G; Reichman B; Casper E; Magill G
J Cancer Res Clin Oncol; 1991; 117(2):151-5. PubMed ID: 2007612
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.
Fennelly D; Wasserheit C; Schneider J; Hakes T; Reich L; Curtin J; Yao TJ; Markman M; Norton L; Crown J
Cancer Res; 1994 Dec; 54(23):6137-42. PubMed ID: 7525055
[TBL] [Abstract][Full Text] [Related]
20. Cis-dichlorodiammine platinum (II) in advanced ovarian carcinoma.
Stewart JF; Tattersall MH; Woods RL; Fox RM
Med J Aust; 1979 Jun; 1(12):548-50. PubMed ID: 470725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
